Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection

OBJECTIVES: The diffusion of the SARS-CoV-2 Delta (B.1.617.2) variant and the waning of immune response after primary Covid-19 vaccination favoured the breakthrough SARS-CoV-2 infections in vaccinated subjects. To assess the impact of vaccination, we determined the severity of infection in hospitali...

Descripción completa

Detalles Bibliográficos
Autores principales: Epaulard, Olivier, Abgrall, Sophie, Lefebvre, Maeva, Faucher, Jean-François, Michon, Jocelyn, Frentiu, Emilia, Blanchi, Sophie, Janssen, Cécile, Charbonnier, Gabrielle, Fresse, Audrey, Laurent, Simon, Sandjakian, Lena, Casez, Pierre, Mahamat, Aba, Beraud, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242694/
https://www.ncbi.nlm.nih.gov/pubmed/35779764
http://dx.doi.org/10.1016/j.cmi.2022.06.019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242694/
https://www.ncbi.nlm.nih.gov/pubmed/35779764
http://dx.doi.org/10.1016/j.cmi.2022.06.019

Ejemplares similares